公司資料
Certara 股價、新聞與催化劑
- 股票代碼:
- CERT
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
8.00 USD (0.00%)
收盤價
最後更新: 2026年8月17日
874M USD
市值
股價為何變動
As of Aug 17, 2026, CERT was little changed and closed at $8.00. No new same-company headline was identified in the current news window.
公司概覽
Model-Informed Drug Development
Certara provides biosimulation software and technology-enabled services used throughout drug discovery, clinical development and regulatory review. Its tools help predict how medicines behave in different patients and dosing scenarios.
Software Portfolio
The company's software includes pharmacokinetic, pharmacodynamic, quantitative-systems-pharmacology and clinical-trial simulation applications. Customers use these products to inform dose selection, study design and regulatory submissions. Certara serves pharmaceutical and biotechnology companies, academic institutions and regulators. Its business combines recurring software subscriptions with scientific consulting and implementation services.
未來催化劑
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。